Gateway Wealth Partners, LLC
Source: SEC Form 13F · as of Mar 2026Gateway Wealth Partners, LLC holds 26 biotech & pharma companies tracked by BioSniper, totaling $37.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$37.5M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 28,993 | $6.3M |
| JNJJOHNSON & JOHNSON | 16,174 | $4.0M |
| LLYELI LILLY & Co | 4,087 | $3.8M |
| ABTABBOTT LABORATORIES | 23,995 | $2.5M |
| PMPhilip Morris International Inc | 14,675 | $2.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,609 | $2.1M |
| MRKMerck & Co., Inc. | 16,631 | $2.0M |
| AMGNAMGEN INC | 4,323 | $1.5M |
| AZNASTRAZENECA PLC | 7,433 | $1.5M |
| GILDGILEAD SCIENCES, INC. | 10,298 | $1.4M |
| UTHRUNITED THERAPEUTICS Corp | 2,404 | $1.4M |
| PFEPFIZER INC | 43,591 | $1.2M |
| MCKMcKesson Corporation | 1,390 | $1.2M |
| CAHCardinal Health Inc. | 3,638 | $769K |
| NVSNovartis AG | 4,616 | $705K |
| CORCencora Inc. | 2,198 | $691K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 10,510 | $580K |
| RPRXRoyalty Pharma plc | 11,774 | $565K |
| BMYBRISTOL MYERS SQUIBB CO | 8,986 | $545K |
| DGXQuest Diagnostics Incorporated | 2,516 | $493K |
| SNYSanofi | 8,163 | $393K |
| ELVElevance Health Inc. | 1,311 | $384K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 832 | $372K |
| IDXXIDEXX LABORATORIES INC /DE | 501 | $282K |
| IQVIQVIA Holdings Inc. | 1,547 | $264K |
| SUNSUNSET ISLAND GROUP | 3,500 | $227K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.